(Q30471886)

16 September 2017

Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C (English)

1 reference

16 September 2017

0 references

1 reference

7

Jean-Pierre Zarski

0 references

Sandrine Bertrais

2

object named as

Sandrine Bertrais

1 reference

16 September 2017

Jérôme Boursier

1

1 reference

16 September 2017

Frédéric Oberti

3

1 reference

16 September 2017

Yves Gallois

4

1 reference

16 September 2017

Isabelle Fouchard-Hubert

5

1 reference

16 September 2017

Marie-Christine Rousselet

6

1 reference

16 September 2017

Jean-Pierre Zarski

7

1 reference

16 September 2017

Paul Calès

8

1 reference

16 September 2017

30 November 2011

1 reference

16 September 2017

1 reference

16 September 2017

11

1 reference

16 September 2017

132

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-230x-11-132

16 September 2017

0 references

cites work

Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Histological grading and staging of chronic hepatitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247188

Sources of variability in histological scoring of chronic viral hepatitis

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

A novel panel of blood markers to assess the degree of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

Exceeding the limits of liver histology markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

Optimization and robustness of blood tests for liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

Liver biopsy: The best, not the gold standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-132

A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis

21 January 2018

1 reference

12 December 2020

Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis

1 reference

12 December 2020

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

1 reference

12 December 2020

Transient elastography (FibroScan)

1 reference

12 December 2020

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-11-132

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference

16 September 2017

PubMed publication ID

22129438

1 reference